Matthew Foy

Matthew Foy

Director/Miembro de la Junta en
Pulmocide Ltd.
.
Health Technology
Finance
Consumer Services

Perfil

Mr. Matthew Foy is an Investor at Asceneuron SA and a Partner at GSK Equity Investments Ltd. He is on the Board of Directors at Akamis Bio Ltd., Fore Biotherapeutics, Inc. and Pulmocide Ltd. Mr. Foy was previously employed as an Independent Director by Decibel Therapeutics, Inc., an Operating Partner by SR One Capital Management LP, a Vice President by Greenhill & Co., Inc., and a Consultant by Longbow Capital Partners LP.
He also served on the board at Progenitor Labs Ltd., Atox Bio Ltd. and Puridify Ltd. He received his undergraduate degree from the University of Oxford, an undergraduate degree from St Peters College Oxford, a graduate degree from the University of Oxford and a graduate degree from St Peters College Oxford.

Cargos activos de Matthew Foy

EmpresasCargoInicio
Inversor de Capital Privado 01/01/2011
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Inversor de Capital Privado 01/09/2015

Antiguos cargos conocidos de Matthew Foy.

EmpresasCargoFin
Director/Miembro de la Junta 25/07/2018
Director/Miembro de la Junta 24/11/2017
GREENHILL & CO., INC. Corporate Officer/Principal 01/01/2010
Inversor de Capital Privado -
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
Ver el detalle de la experiencia de Matthew Foy.

Formación de Matthew Foy.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

78

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Finance